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CASE REPORT Open Access
Ex-vivo recruitment and x-ray assessment
of donor lungs in a challenging retrieval
from a donor supported by lvad using the
portable normothermic perfusion system: a
case report
Marco Schiavon1*†, Francesca Calabrese1†, Guido Di Gregorio2, Monica Loy1, Giuseppe Marulli1,
Alessandro Rebusso1, Fiorella Calabrese3 and Federico Rea1
Abstract
Background: Lung transplantation (LTx) is limited by the shortage of suitable donors. To overcome this problem,
many programs have begun to use donors with extended criteria (marginal donors). However, brain-dead patients
with implanted mechanical circulatory support system have rarely been considered as potential lung donors. This
case demonstrates the feasibility of lung transplantations from organ donors supported by a mechanical circulatory
support system despite the possible difficulties of lung retrieval.
Case presentation: Our case presents a successful procurement and bilateral lung transplantation from a donor
supported by a left ventricular assist device (LVAD) who experienced an intraoperatively haemodynamic complication.
The use of portable normothermic perfusion device let us to reduce ischemic injury and assess these marginal donor
lungs helping us to determine the clinical suitability for transplantation. Given our extensive experience with the device
instrumentation and management, the EVLP process was uneventful with excellent post-transplant course.
Conclusions: This case report demonstrates the feasibility of lung transplantations from organ donors supported by a
mechanical circulatory support system using the portable normothermic perfusion platform to assess and preserve
these donor lungs.
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Background
Lung transplantation represents the gold-standard therapy
for patients with end stage lung disease. However, only
about 15% of lungs from multiorgan donors are used for
transplantation even if the selection criteria for donor
lungs have been extended [1, 2]. For many years, brain
dead patients with implanted mechanical circulatory
support system have not been considered as potential
lung donors. Recently, three cases of lung procure-
ment from a donor with a circulatory support devices
were reported [3–5].
In these reports, lungs procurement required a careful
anatomical preparation of heart and lungs because many
surgical difficulties during retrieval might occur.
When this happens, we may face two different situ-
ation: on the one hand the risk of not being able to fully
assess the suitability of the organ, on the other side a
lung deterioration which may impair its function.
Nowadays the use of Ex Vivo Lung Perfusion (EVLP)
platform to question and evaluate marginal lungs is part
of clinical practice as demonstrated by several studies
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[6–8] even if to our knowledge no cases of EVLP
procedure were reported in this kind of donors.
In our case, we report and confirm the possibility to
use lungs from a donor supported by a left ventricular
assist device after ex-vivo recruitment and assessment
using the Organ Care System (OCS) Lung (Transmedics,
Andover, MA, USA) platform in case of difficult retrieval.
Case presentation
A 54-year old male, brain dead donor was evaluated and
assigned to our centre for organ donation by the North
Italian Transplant program (NITp), our network for
organ sharing. The donor was recovering in our hos-
pital post-LVAD implantation (HeartWare®, HeartWare
International, Inc., USA) as a bridge to heart transplant-
ation for dilated ischemic cardiomyopathy (Fig. 1).
Cardiac catheterization, performed before the VAD
implantation, showed pulmonary hypertension with a
mean pulmonary arterial pressure of 42 mmHg, a
wedge pressure of 38 mmHg, and normal arteriolar
resistance (1.2 HRU).
The cardiac procedure was performed through left
anterior thoracotomy with insertion of outflow cannula
in the left axillary artery. The post-operative course was
uneventful for 16 days when a subarachnoid haemor-
rhage occurred causing brain death.
The donor was intubated 3 days prior the retrieval and
the PaO2/FiO2 ratio (FiO2 100%) at the moment of the
call was 511 mmHg. The chest x-ray showed reduced
bilateral lung expansion, bronchoscopy was normal, with-
out signs of current infection or aspiration. Eurotransplant
donor score [9] was 10.
After a median sternotomy, we proceeded with special
care to the inspection of thoracic organs. At the opening
of the left pleura, we observed the presence of strong
adhesions between the left lung and the outflow cannula.
Gentle and careful preparation was required to avoid
lung injuries and bleeding complication. At the inspection,
the donor lungs did not present signs of infiltrations with
a slight degree of edema in the lower lobes, the PaO2/
FiO2 ratio was 583 mmHg (FiO2100%, PEEP: 5 cm H20,
Tidal Volume: 6 ml/Kg/min) and, therefore, we start to
prepare the operative room for transplantation.
Abdominal procedures for liver and kidneys retrieval
started but during these manoeuvres, several episodes of
severe hypotension occurred, poorly responsive to drugs
with risk of sudden right ventricular failure. During a
new inspection, lung appeared heavier in comparison to
before, mainly due to a small increase of lung edema. In
addition, the anesthesiologist was in doubt about the
risks of new hypotensive episodes in the donor.
Therefore, considering the risk of organ hypoperfusion
and potential lung deterioration from RV failure, we
decided to proceed immediately to retrieval with using
the OCS lung to perform ex-vivo assessment of these
lung and also to minimize donor lung ischemia since the
patient was not yet in the operative room.
The OCS was prepped and primed simultaneously
with the surgical procurement of the donor lungs in
around 20 min. Following injection of heparin, pulmon-
ary cannulation and aortic cross-clamping, the LVAD
was deactivated by cutting the driveline. Perfusion with
5 l of Celsior® (4 l anterogradely supplemented with
50 mg nytroglicerine and 1 l retrogradely) and explant-
ation of the double lung block followed standard proto-
cols. After 53 min of instrumentation time, the lungs
were connected to OCS Lung starting normothermic
perfusion. Concurrently recipient preparation was inter-
rupted waiting for a more extensive evaluation of lungs
function through OCS device.
After 340 min of OCS Lung running time, arterial
blood gas (PaO2/FiO2 from 476 mmHg to 525 mmHg)
analysis, visual and bronchoscopic evaluation, arterial
pulmonary pressure (mean value 11 mmHg), pulmonary
and airway resistance (Fig. 2a, b) improved and were sat-
isfactory. In addition, a lung-x-ray on the device was
performed, excluding any abnormalities (Fig. 3a, b).
At this point, the anaesthesiological preparation of
recipient restarted and lungs were prepared for implant-
ation. The recipient was a 61 year-old male affected by idio-
pathic pulmonary fibrosis without pulmonary hypertension.
Bilateral lung transplantation was performed via clam-
shell incision for the presence of pleural adhesions; no
extra corporeal membrane oxygenation was needed.
Total cold ischemic time was 183 min for the right lung
and 292 min for the left side.
In Intensive Care Unit, the severity of primary graft dys-
function (PGD) was calculated according to International
Society for Heart and Lung Transplantation (ISHLT)
Fig. 1 Chest X-ray of the multiorgan donor with an implanted LVAD
one day before the donation
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recommendations [10] and resulted respectively 3,2,2,0 at
T-0, T24, T48 and T72.
The patient was extubated on day 3 and discharged on
postoperative day 33 with an uneventful post-operative
course.
Scheduled trans-bronchial biopsy performed before
discharge resulted positive for mild acute cellular rejec-
tion without bronchiolar involvement (grade A2B0) [11].
The patient was treated with high-dose intravenous ster-
oid and discharged from the hospital with a satisfactory
chest X-ray and arterial blood gas exchange.
To date, after 12 months follow-up, the patient is alive
with satisfactory condition, without sign of acute rejec-
tion at the trans-bronchial biopsies.
Discussion and Conclusions
The organ shortage remains a key limiting factor to the
widespread application of lung transplantation [1].
Among the options available to increase the donor pool,
the use of marginal or extended donors [12, 13] is cer-
tainly one of the most pursued and adopted. Brain-dead
patients with an implanted LVAD have rarely considered
as potential lungs donors since the presence of prior car-
diopulmonary surgery was usually considered as a relative
contraindication to pulmonary donation [14]. The pres-
ence of mechanical circulatory support may be associated
with different serious adverse events, including infection,
bleeding, thromboembolism, neurologic disorders, right
ventricular failure and multi-organ dysfunction resulting
in poor consequences for pulmonary donation [15].
In addition, patients needing LVAD implantation present
a poor cardiac function with presence of pulmonary hyper-
tension, previous episode of lung edema and risk of organ
damages.
However, the role of mechanical support for both
acute and chronic heart failure is rapidly growing and
this donor population will certainly increase in the com-
ing years. To our knowledge, successful transplantation
Fig. 2 Overtime pulmonary vascular resistance (a) and peak airway pressure (b) trend during OCS running time showed an improvement/stability
of lung parameters during normothermic perfusion
Fig. 3 Lung X-ray in the OCS device showing no sign of oedema, infection or other abnormalities in the right (a) and in the left lung (b)
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of lungs from a donor with mechanical circulatory sup-
port has been limited [3–5]. In these reports, donors
were younger than our borderline age donor and the
duration of LVAD support before retrieval varies from
1 day to 1 year after implantation.
The retrieval procedure may be, in these cases, most
critical. Cardiac redo operations after LVAD implant-
ation are high-risk procedures, due to the presence of
the device itself and dense pleural adhesions on the left side
that could increase the risk of complications. Differently
from the other studies where no anaesthesiologic issues
were reported during retrieval, our case was further com-
plicated by severe hemodynamic instability resulting in
severe RV failure, that risked compromising our ability to
use these lungs as demonstrated by the increase in lung
edema at the inspection. Therefore we decided to immedi-
ately retrieve the organs using the OCS device with two
aims: organ revaluation and reduction of ischemia.
Thanks to the OCS device, we were able to evaluate
functional and hemodynamic parameters of the lungs.
In particular, despite the donor history of pulmonary
hypertension, related to left cardiac failure before LVAD
implantation, mean pulmonary artery pressure and vascu-
lar resistance were normal during normothermic perfu-
sion, with an excellent transplantation outcome.
In addition to standard clinical EVLP indices, we also
performed a radiographic assessment that is particularly
useful to carefully exclude the presence of any unrecognized
inflammatory/infectious processes that can complicate the
post-operative outcome [16].
Compared to static EVLP system, the OCS device has
the benefit to monitor lung function since the beginning
of normothermic perfusion avoiding any cold transport,
that may further compromise lung viability.
The policy of our surgical team is to usually bring the
OCS system device in all lung procurement, since some
negative findings may be observed during retrieval
(technical issues, organ deterioration,.,.).
To assess and to categorize donor lung quality, we
generally use Eurotransplant donor score [9]. Despite a
donor score above 6 generally indicates a marginal
donor, as in our experience, a precise cut-off to
discharge donors is not present but it depends on single
parameters and on the combination of them. Nevertheless,
the score records may prospectively lead us to better
understand the impact of donor characteristics on post-
operative results.
Moreover, the use of the OCS Lung and its ability to
minimize ischemic injury enabled us to time and coordin-
ate the recipient’s procedure. As we previously mentioned
the recipient was not in operating room, so the estimated
cold ischemia time was higher than 6 h. Prolonged ische-
mic time has been suggested as a risk factor for the
development of PGD [17–20]; the response to ischemia of
the organ is highly dependent on many conditions including
age and underlying lung conditions at the time of
retrieval [21]. While standard donor lungs can tolerate
very well up to 8–12 h of cold static inflation with low
rates of PGD, the alterations in a marginal organ (i.e.
edematous lungs, LVAD implantation, and previous
pulmonary hypertension) may result in a higher risk of
graft dysfunction. In our case PGD score naturally
favorable evolved toward a score of 0 at 72 h.
Finally, the avoiding of cold ischemia should be par-
ticularly pursued when donor and recipient are in the
same hospital as the time for organ transport is absent.
In summary, this case demonstrates the practicability
and technical feasibility of lung donation despite an
implanted LVAD system supporting the donor’s failing
heart. We report the use of the portable of OCS EVLP
system as an aid to preserve and assess these marginal
donor lungs especially in urgent retrieval situation. Brain
dead patients with an implanted mechanical circulatory
device should be seriously considered and evaluated for
lung donation to potentially expand donor pool and give
a transplant possibility to our recipient.
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